Literature DB >> 4150990

The role of dihydropyrimidinase in the metabolism of some hydantoin and succinimide drugs.

K H Dudley, T C Butler, D L Bius.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4150990

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN： 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  7 in total

1.  Dihydropyrimidine amidohydrolases and dihydroorotases share the same origin and several enzymatic properties.

Authors:  Zoran Gojkovic; Lise Rislund; Birgit Andersen; Michael P B Sandrini; Paul F Cook; Klaus D Schnackerz; Jure Piskur
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

Review 2.  Degradation of purines and pyrimidines by microorganisms.

Authors:  G D Vogels; C Van der Drift
Journal:  Bacteriol Rev       Date:  1976-06

3.  Cyclic-imide-hydrolyzing activity of D-hydantoinase from Blastobacter sp. strain A17p-4.

Authors:  C L Soong; J Ogawa; M Honda; S Shimizu
Journal:  Appl Environ Microbiol       Date:  1999-04       Impact factor: 4.792

4.  Novel Metabolic Transformation Pathway for Cyclic Imides in Blastobacter sp. Strain A17p-4.

Authors:  J Ogawa; C L Soong; M Honda; S Shimizu
Journal:  Appl Environ Microbiol       Date:  1996-10       Impact factor: 4.792

5.  Cloning, sequencing, and expression in Escherichia coli of the D-hydantoinase gene from Pseudomonas putida and distribution of homologous genes in other microorganisms.

Authors:  G LaPointe; S Viau; D LeBlanc; N Robert; A Morin
Journal:  Appl Environ Microbiol       Date:  1994-03       Impact factor: 4.792

6.  UHPLC-MS/MS method for analysis of sobuzoxane, its active form ICRF-154 and metabolite EDTA-diamide and its application to bioactivation study.

Authors:  Petra Reimerová; Anna Jirkovská; Hana Bavlovič Piskáčková; Galina Karabanovich; Jaroslav Roh; Tomáš Šimůnek; Petra Štěrbová-Kovaříková
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

7.  Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models.

Authors:  N Takahashi; L Duprez; S Grootjans; A Cauwels; W Nerinckx; J B DuHadaway; V Goossens; R Roelandt; F Van Hauwermeiren; C Libert; W Declercq; N Callewaert; G C Prendergast; A Degterev; J Yuan; P Vandenabeele
Journal:  Cell Death Dis       Date:  2012-11-29       Impact factor: 8.469
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.